Exchange Traded Concepts, LLC
- SEC CIK
- 0001457320
- Latest filing
- Aug 11, 2026
RCUS holding history
Arcus Biosciences, Inc. in every 13F filed by Exchange Traded Concepts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RCUS overviewAll 13F holders of RCUSFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −13,922−100.0% | Sold out | Holders |
| Q1 2025 | 13,922 | $109.3K | <0.1% | +4,013+40.5% | Added | Holders |
| Q4 2024 | 9,909 | $147.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 9,909 | $151.5K | <0.1% | −1,954−16.5% | Reduced | Holders |
| Q2 2024 | 11,863 | $180.7K | <0.1% | −3,690−23.7% | Reduced | Holders |
| Q1 2024 | 15,553 | $293.6K | <0.1% | +8,737+128.2% | Added | Holders |
| Q4 2023 | 6,816 | $130.2K | <0.1% | +1,729+34.0% | Added | Holders |
| Q3 2023 | 5,087 | $91.3K | <0.1% | −1,888−27.1% | Reduced | Holders |
| Q2 2023 | 6,975 | $141.7K | <0.1% | +6,975 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −28,445−100.0% | Sold out | Holders |
| Q4 2022 | 28,445 | $588.2K | <0.1% | +948+3.4% | Added | Holders |
| Q3 2022 | 27,497 | $719.0K | <0.1% | +27,497 | New | Holders |